Stay updated with breaking news from Naomi Eichenbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
--Phase 1 clinical trial will evaluate safety and immunogenicity of several formulations of SCB-2020S as a 2-dose vaccination series in adults----SCB-
17.05.2022 - SHANGHAI, China, May 17, 2022 (GLOBE NEWSWIRE) - Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced its participation ...
Clover Appoints LiongHo Chua as President of Greater China GlobeNewswire April 27, 2022 SHANGHAI, China, April 27, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Mr. LiongHo Chua as President of Greater China....
Clover Appoints LiongHo Chua as President of Greater China - read this article along with other careers information, tips and advice on BioSpace
--Significant neutralizing antibodies against Omicron induced by SCB-2019 third dose in both homologous and heterologous booster settings-- Clover Biopharmaceuticals, Ltd. , a global... | March 17, 2022